- Home
- RVNC vs MNMD Comparison
RVNC vs MNMD Comparison
Compare RVNC & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- MNMD
- Stock Information
- Founded
- RVNC 1999
- MNMD 2019
- Country
- RVNC United States
- MNMD United States
- Employees
- RVNC N/A
- MNMD N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- MNMD Pharmaceuticals and Biotechnology
- Sector
- RVNC Health Care
- MNMD Health Care
- Exchange
- RVNC Nasdaq
- MNMD Nasdaq
- Market Cap
- RVNC 599.6M
- MNMD 485.5M
- IPO Year
- RVNC 2014
- MNMD N/A
- Fundamental
- Price
- RVNC $5.78
- MNMD $7.52
- Analyst Decision
- RVNC Buy
- MNMD Strong Buy
- Analyst Count
- RVNC 10
- MNMD 9
- Target Price
- RVNC $10.86
- MNMD $28.75
- AVG Volume (30 Days)
- RVNC 1.6M
- MNMD 879.7K
- Earning Date
- RVNC 11-19-2024
- MNMD 11-07-2024
- Dividend Yield
- RVNC N/A
- MNMD N/A
- EPS Growth
- RVNC N/A
- MNMD N/A
- EPS
- RVNC N/A
- MNMD N/A
- Revenue
- RVNC $251,178,000.00
- MNMD N/A
- Revenue This Year
- RVNC $20.36
- MNMD N/A
- Revenue Next Year
- RVNC $31.66
- MNMD N/A
- P/E Ratio
- RVNC N/A
- MNMD N/A
- Revenue Growth
- RVNC 40.23
- MNMD N/A
- 52 Week Low
- RVNC $2.30
- MNMD $2.41
- 52 Week High
- RVNC $9.75
- MNMD $12.22
- Technical
- Relative Strength Index (RSI)
- RVNC 56.47
- MNMD 70.56
- Support Level
- RVNC $5.67
- MNMD $5.87
- Resistance Level
- RVNC $5.97
- MNMD $6.43
- Average True Range (ATR)
- RVNC 0.19
- MNMD 0.42
- MACD
- RVNC 0.06
- MNMD 0.09
- Stochastic Oscillator
- RVNC 78.01
- MNMD 76.04
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About MNMD Mind Medicine (MindMed) Inc.
Mind Medicine Inc is a biopharmaceutical company. The company produces to treat brain health disorders. The company discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances. The firm is having an approach towards developing the next generation of psychedelic-inspired medicines and therapies.